We are excited to share a major milestone in the advancement of our technology within the thoracic oncology field. Research presented by a team from the University of Pennsylvania and Integro Theranostics at the recent IASLC 2025 World Conference on…
In fluorescence-guided surgery and NIR tissue imaging, users are constantly pushing image acquisition systems to their performance limits. The ability to make accurate, quantitative decisions—such as pathologic determinations by tumor-to-background ratio (TBR) or tussie margins —depends entirely on the consistency…
In the exciting world of molecular imaging and fluorescence-guided surgery (FGS), the ability to see tumors and tissue boundaries in real-time is revolutionary. But for this technology to move from simple visual guidance to a reliable, reimbursable clinical tool, we…